Riverview Trust Company’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10
| Closed | -$657 | – | 625 |
|
|
2024
Q4 | $657 | Buy |
10
+3
| +43% | +$197 | ﹤0.01% | 729 |
|
|
2024
Q3 | $492 | Sell |
7
-204
| -97% | -$14.3K | ﹤0.01% | 794 |
|
|
2024
Q2 | $17.4K | Hold |
211
| – | – | 0.02% | 493 |
|
|
2024
Q1 | $18.4K | Buy |
+211
| New | +$18.4K | 0.01% | 516 |
|
|
2023
Q4 | – | Sell |
-211
| Closed | -$18.7K | – | 157 |
|
|
2023
Q3 | $18.7K | Hold |
211
| – | – | 0.02% | 415 |
|
|
2023
Q2 | $18.3K | Hold |
211
| – | – | 0.02% | 399 |
|
|
2023
Q1 | $20.5K | Hold |
211
| – | – | 0.02% | 338 |
|
|
2022
Q4 | $22K | Hold |
211
| – | – | 0.02% | 319 |
|
|
2022
Q3 | $18K | Hold |
211
| – | – | 0.02% | 385 |
|
|
2022
Q2 | $17K | Hold |
211
| – | – | 0.01% | 433 |
|
|
2022
Q1 | $16K | Buy |
+211
| New | +$16K | 0.01% | 578 |
|